Patent ID: 8158154
Filing Date: 2012-04-17
Classification: A61K,A61L,A61P

Abstract:
1. A method of treating one or more symptoms of rhinitis comprising the steps of applying to an individual's nasal mucosa a microcrystalline suspension of beclomethasone particles suspended in an aqueous medium, said suspension comprising about 0.01% to about 1% of beclomethasone and having the following particle size distribution: about 10% of the beclomethasone particles have a particle size of less than 0.3 microns; (ii) about 25% of the beclomethasone particles have a particle size of less than 0.55 microns; (iii) about 50% of the beclomethasone particles have a particle size of less than 1.1 microns; (iv) about 75% of the beclomethasone particles have a particle size of less than 1.8 microns; and (v) about 90% of the beclomethasone particles have a particle size of less than 2.7 microns; wherein the suspension is suitable for administration to the nasal mucosa of an individual.